VALDEMBRI, Donatella
VALDEMBRI, Donatella
ONCOLOGIA
3D simulations of early blood vessel formation
2007-01-01 CAVALLI F; GAMBA A; NALDI G; M. SEMPLICE; VALDEMBRI D; SERINI G
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent
2018-01-01 Gioelli, Noemi; Maione, Federica; Camillo, Chiara; Ghitti, Michela; Valdembri, Donatella; Morello, Noemi; Darche, Marie; Zentilin, Lorena; Cagnoni, Gabriella; Qiu, Yaqi; Giacca, Mauro; Giustetto, Maurizio; Paques, Michel; Cascone, Ilaria; Musco, Giovanna; Tamagnone, Luca; Giraudo, Enrico; Serini, Guido
Aminopeptidase A is a functional target in angiogenic blood vessels
2004-01-01 MARCHIÒ S; LAHDENRANTA J; SCHLINGEMANN RO; VALDEMBRI D; WESSELING P; ARAP MA; HAJITOU A; OZAWA MG; TREPEL M; GIORDANO RJ; NANUS DM; DIJKMAN HB; OOSTERWIJK E; SIDMAN RL; COOPER MD; BUSSOLINO F; PASQUALINI R; ARAP W
Angiogenesis: a balancing act between integrin activation and inhibition?
2009-01-01 Bussolino F; Caccavari F; Valdembri D; Serini G
Angiogenesis: The Importance of RHOJ-Mediated Trafficking of Active Integrins
2020-01-01 Valdembri D.; Serini G.
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs
2008-01-01 ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D
Axonal precursor miRNAs hitchhike on endosomes and locally regulate the development of neural circuits
2020-01-01 Corradi, Eloina; Dalla Costa, Irene; Gavoci, Antoneta; Iyer, Archana; Roccuzzo, Michela; Otto, Tegan A; Oliani, Eleonora; Bridi, Simone; Strohbuecker, Stephanie; Santos-Rodriguez, Gabriela; Valdembri, Donatella; Serini, Guido; Abreu-Goodger, Cei; Baudet, Marie-Laure
CCL16 activates an angiogenic program in vascular endothelial cells
2004-01-01 Strasly M; Doronzo G; Cappello P; Valdembri D; Arese M; Mitola S; Moore P; Alessandri G; Giovarelli M; Bussolino F.
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.
2003-01-01 SERINI G; VALDEMBRI D; ZANIVAN S; MORTERRA G; BURKHARDT C; CACCAVARI F; ZAMMATARO L; PRIMO L; L. TAMAGNONE; LOGAN M; TESSIER-LAVIGNE M; TANIGUCHI M; PUSCHEL AW; BUSSOLINO F
Class 3 semaphorins in cardiovascular development
2016-01-01 Valdembri, Donatella; Regano, Donatella; Maione, Federica; Giraudo, Enrico; Serini, Guido
Conformationally active integrin endocytosis and traffic: why, where, when and how?
2020-01-01 Mana, Giulia; Valdembri, Donatella; Serini, Guido
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3
2021-01-01 Coppo R.; Orso F.; Virga F.; Dalmasso A.; Baruffaldi D.; Nie L.; Clapero F.; Dettori D.; Quirico L.; Grassi E.; Defilippi P.; Provero P.; Valdembri D.; Serini G.; Sadeghi M.M.; Mazzone M.; Taverna D.
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease
2006-01-01 COLUCCI S; TARABOLETTI G; PRIMO L; VIALE A; ROCA C; VALDEMBRI D; GEUNA M; PAGANO M; GRANO M; POGREL AM; HARRIS AL; ATHANASOU NN; MANTOVANI A; ZALLONE A; BUSSOLINO F
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
2002-01-01 SGADARI C; BACILLARI G; TOSCHI E; CARLEDI D; BACICALUPPO I; BACCARINI S; PALLADINO C; LEONE S; VALDEMBRI D; F. BUSSOLINO; MONINI P; ENSOLI B
HIV protease inhibitors block angiogenesis and promote regression of Kaposi's sarcoma in the nude mouse model
2002-01-01 Sgadari C; Carlei D; Barillari G; Toschi E; Bacigalupo I; Palladino C; Malavasi L; Baccarini S; Bugarini R; Marinelli R; Falchi M; D. Valdembri ; F. Bussolino ; Monini P; Ensoli
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.
2003-01-01 ROCA C; PRIMO L; VALDEMBRI D; CIVIDALLI A; DECLERK P; CARMELIET P; GABRIELE P; F. BUSSOLINO
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF
2002-01-01 VALDEMBRI D; G. SERINI; VACCA A; RIBATTI D; BUSSOLINO F
Increasing traffic on vascular routes
2011-01-01 M. Santambrogio; D. Valdembri; G. Serini
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
2005-01-01 GALLICCHIO M; MITOLA S; VALDEMBRI D; FANTOZZI R; VARNUM B; AVANZI GC; BUSSOLINO F
Integrin signaling and lung cancer
2010-01-01 Caccavari F; Valdembri D; Sandri C; Bussolino F; Serini G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3D simulations of early blood vessel formation | 2007 | CAVALLI F; GAMBA A; NALDI G; M. SEMPLICE; VALDEMBRI D; SERINI G | |
| A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent | 2018 | Gioelli, Noemi; Maione, Federica; Camillo, Chiara; Ghitti, Michela; Valdembri, Donatella; Morello, Noemi; Darche, Marie; Zentilin, Lorena; Cagnoni, Gabriella; Qiu, Yaqi; Giacca, Mauro; Giustetto, Maurizio; Paques, Michel; Cascone, Ilaria; Musco, Giovanna; Tamagnone, Luca; Giraudo, Enrico; Serini, Guido | |
| Aminopeptidase A is a functional target in angiogenic blood vessels | 2004 | MARCHIÒ S; LAHDENRANTA J; SCHLINGEMANN RO; VALDEMBRI D; WESSELING P; ARAP MA; HAJITOU A; OZAWA MG; TREPEL M; GIORDANO RJ; NANUS DM; DIJKMAN HB; OOSTERWIJK E; SIDMAN RL; COOPER MD; BUSSOLINO F; PASQUALINI R; ARAP W | |
| Angiogenesis: a balancing act between integrin activation and inhibition? | 2009 | Bussolino F; Caccavari F; Valdembri D; Serini G | |
| Angiogenesis: The Importance of RHOJ-Mediated Trafficking of Active Integrins | 2020 | Valdembri D.; Serini G. | |
| AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs | 2008 | ORSO F; PENNA E; CIMINO D; ASTANINA E; MAIONE F; VALDEMBRI D; GIRAUDO E; SERINI G; SISMONDI P; DE BORTOLI M; TAVERNA D | |
| Axonal precursor miRNAs hitchhike on endosomes and locally regulate the development of neural circuits | 2020 | Corradi, Eloina; Dalla Costa, Irene; Gavoci, Antoneta; Iyer, Archana; Roccuzzo, Michela; Otto, Tegan A; Oliani, Eleonora; Bridi, Simone; Strohbuecker, Stephanie; Santos-Rodriguez, Gabriela; Valdembri, Donatella; Serini, Guido; Abreu-Goodger, Cei; Baudet, Marie-Laure | |
| CCL16 activates an angiogenic program in vascular endothelial cells | 2004 | Strasly M; Doronzo G; Cappello P; Valdembri D; Arese M; Mitola S; Moore P; Alessandri G; Giovarelli M; Bussolino F. | |
| Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. | 2003 | SERINI G; VALDEMBRI D; ZANIVAN S; MORTERRA G; BURKHARDT C; CACCAVARI F; ZAMMATARO L; PRIMO L; L. TAMAGNONE; LOGAN M; TESSIER-LAVIGNE M; TANIGUCHI M; PUSCHEL AW; BUSSOLINO F | |
| Class 3 semaphorins in cardiovascular development | 2016 | Valdembri, Donatella; Regano, Donatella; Maione, Federica; Giraudo, Enrico; Serini, Guido | |
| Conformationally active integrin endocytosis and traffic: why, where, when and how? | 2020 | Mana, Giulia; Valdembri, Donatella; Serini, Guido | |
| ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 | 2021 | Coppo R.; Orso F.; Virga F.; Dalmasso A.; Baruffaldi D.; Nie L.; Clapero F.; Dettori D.; Quirico L.; Grassi E.; Defilippi P.; Provero P.; Valdembri D.; Serini G.; Sadeghi M.M.; Mazzone M.; Taverna D. | |
| Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease | 2006 | COLUCCI S; TARABOLETTI G; PRIMO L; VIALE A; ROCA C; VALDEMBRI D; GEUNA M; PAGANO M; GRANO M; POGREL AM; HARRIS AL; ATHANASOU NN; MANTOVANI A; ZALLONE A; BUSSOLINO F | |
| HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. | 2002 | SGADARI C; BACILLARI G; TOSCHI E; CARLEDI D; BACICALUPPO I; BACCARINI S; PALLADINO C; LEONE S; VALDEMBRI D; F. BUSSOLINO; MONINI P; ENSOLI B | |
| HIV protease inhibitors block angiogenesis and promote regression of Kaposi's sarcoma in the nude mouse model | 2002 | Sgadari C; Carlei D; Barillari G; Toschi E; Bacigalupo I; Palladino C; Malavasi L; Baccarini S; Bugarini R; Marinelli R; Falchi M; D. Valdembri ; F. Bussolino ; Monini P; Ensoli | |
| Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. | 2003 | ROCA C; PRIMO L; VALDEMBRI D; CIVIDALLI A; DECLERK P; CARMELIET P; GABRIELE P; F. BUSSOLINO | |
| In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF | 2002 | VALDEMBRI D; G. SERINI; VACCA A; RIBATTI D; BUSSOLINO F | |
| Increasing traffic on vascular routes | 2011 | M. Santambrogio; D. Valdembri; G. Serini | |
| Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor | 2005 | GALLICCHIO M; MITOLA S; VALDEMBRI D; FANTOZZI R; VARNUM B; AVANZI GC; BUSSOLINO F | |
| Integrin signaling and lung cancer | 2010 | Caccavari F; Valdembri D; Sandri C; Bussolino F; Serini G |